Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Research & Development (2020 - 2025)

Historic Research & Development for INVO Fertility (IVF) over the last 9 years, with Q2 2025 value amounting to $127807.0.

  • INVO Fertility's Research & Development changed N/A to $127807.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $878250.0, marking a year-over-year increase of 804174.47%. This contributed to the annual value of $489660.0 for FY2024, which is 19507.37% up from last year.
  • Latest data reveals that INVO Fertility reported Research & Development of $127807.0 as of Q2 2025.
  • In the past 5 years, INVO Fertility's Research & Development ranged from a high of $484780.0 in Q4 2024 and a low of $2668.0 during Q3 2023
  • In the last 5 years, INVO Fertility's Research & Development had a median value of $73677.5 in 2022 and averaged $113096.8.
  • As far as peak fluctuations go, INVO Fertility's Research & Development crashed by 9847.78% in 2023, and later soared by 810687.32% in 2024.
  • Over the past 5 years, INVO Fertility's Research & Development (Quarter) stood at $63756.0 in 2021, then increased by 15.81% to $73835.0 in 2022, then crashed by 92.0% to $5907.0 in 2023, then skyrocketed by 8106.87% to $484780.0 in 2024, then crashed by 73.64% to $127807.0 in 2025.
  • Its last three reported values are $127807.0 in Q2 2025, $265663.0 for Q1 2025, and $484780.0 during Q4 2024.